ADC Therapeutics SA (ADCT) stock is lower by -10.05% since Friday, May 15, 2020 when ADC Therapeutics SA began trading, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ADCT stock a score of 34 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 5. ADCT's rank also includes a short-term technical score of 8. The fundamental score for ADCT is 89. In addition to the average rating from Wall Street analysts, ADCT stock has a mean target price of 48.75. This means analysts expect the stock to increase 82.79% over the next 12 months.
What's Happening with ADCT Stock Today
ADC Therapeutics SA (ADCT) stock is lower by -1.51% while the S&P 500 is lower by -0.15% as of 11:48 AM on Wednesday, Mar 3. ADCT is lower by -$0.41 from the previous closing price of $27.08 on volume of 104,538 shares. Over the past year the S&P 500 is higher by 34.94% while ADCT is lower by -10.05%. ADCT lost -$1.52 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on ADC Therapeutics SA (ADCT) Stock.
